Literature DB >> 8640197

Anorexia nervosa following gastroplasty in the male: two cases.

O B Bonne1, R Bashi, E M Berry.   

Abstract

The first stage in the development of anorexia nervosa involves voluntary restriction of food intake, that is, diet. Marked weight loss, impairment in body image, and deterioration of health ensue. Anorexia nervosa is much more prevalent among women than men. Its etiology and presentation are mostly similar for both sexes. Certain features, such as greater premorbid obesity and sexual identity concerns, are thought to be more prevalent in male patients. We present 2 male patients who had undergone gastroplasty for morbid obesity and subsequently developed anorexia nervosa. Both evinced signs of identity confusion. Neither one of the patients underwent psychiatric evaluation before surgery. The cases described illustrate that anorexia nervosa may succeed acute and marked weight loss following gastroplasty. This emphasizes the need for a psychiatric assessment before bariatric surgery, and should alert clinicians to search for elements that may predispose vulnerable individuals to a risk of developing anorexia nervosa.

Entities:  

Mesh:

Year:  1996        PMID: 8640197     DOI: 10.1002/(SICI)1098-108X(199601)19:1<105::AID-EAT13>3.0.CO;2-V

Source DB:  PubMed          Journal:  Int J Eat Disord        ISSN: 0276-3478            Impact factor:   4.861


  3 in total

1.  Massive weight loss without surgery in a super obese patient.

Authors:  Rebecca Marzocchi; Davide Cappellari; Riccardo Dalle Grave; Giulio Marchesini
Journal:  Obes Surg       Date:  2009-10-20       Impact factor: 4.129

2.  Personal Descriptions of Life Before and After Bariatric Surgery From Overweight or Obese Men.

Authors:  Karen-Leigh Edward; Michael W Hii; Jo-Ann Giandinoto; Julie Hennessy; Lisa Thompson
Journal:  Am J Mens Health       Date:  2016-02-04

3.  Exploring the Experiences of Women Who Develop Restrictive Eating Behaviours After Bariatric Surgery.

Authors:  Charlotte Watson; Afsane Riazi; Denise Ratcliffe
Journal:  Obes Surg       Date:  2020-06       Impact factor: 4.129

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.